TY  - JOUR

T1  - Assessing the long-term effectiveness of cladribine vs. placebo in the relapsing-remitting multiple sclerosis CLARITY randomized controlled trial and CLARITY extension using treatment switching adjustment methods

JO  - Advances in Therapy

UR  - https://eprints.whiterose.ac.uk/id/eprint/153094

PY  - 2020/01/01

AU  - Bell Gorrod H

AU  - Latimer NR

AU  - Damian D

AU  - Hettle R

AU  - Harty GT

AU  - Wong SL

ED  - 

DO  - DOI: 10.1007/s12325-019-01140-z

PB  - Springer Nature

VL  - 17

IS  - 1

SP  - 225

EP  - 239

Y2  - 2025/10/31

ER  -